Literature DB >> 30225558

Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.

Xue Li1, Yu-Quan Qian1, Na Liu1, Rong Mu1, Yu Zuo1,2, Guo-Chun Wang2, Yuan Jia3, Zhan-Guo Li4.   

Abstract

To investigate the clinical pattern, survival rate, causes of death and risk factors in a large cohort of Chinese Han patients with systemic sclerosis (SSc). Inpatients treated from 2002 to 2014 were included in this study. Patients were classified into diffuse cutaneous SSc (dcSSc), limited cutaneous SSc (lcSSc), and SSc-overlap syndrome groups. Data were analyzed using Chi-squared tests, Kaplan-Meier curves, log-rank tests, and Cox proportional hazards modeling. Among a total of 201 patients, dcSSc (50.2%) was the major subtype, followed by lcSSc (30.3%) and SSc-overlap (19.4%). Interstitial lung disease (ILD, 148/201, 74%) was the most frequent organ involvement. The overall survival rates were 98% and 95% at 5 and 10 years, respectively. The overall standard mortality ratio (SMR) was 2.22. The most common cause of death was ILD combined with infection (8/16, 50%), followed by kidney failure (2/16, 12.5%). On crude analysis, pulmonary hypertension, ILD, cardiac involvements, renal involvements, and digital ischemia were associated with poor prognosis. On multivariate analysis, pericardial effusion (p = 0.000) and digital ischemia (p = 0.016) were independent prognostic factors of death. The mortality rate of patients with SSc is mildly increased in comparison with the general population. ILD is the most common systemic involvement and the principal cause of death in SSc. Pericardial effusion and digital ischemia are independent factors associated with death.

Entities:  

Keywords:  Clinical pattern; Death causes; Risk factor; Survival; Systemic sclerosis

Mesh:

Year:  2018        PMID: 30225558     DOI: 10.1007/s10067-018-4291-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

Review 2.  Mortality and survival in systemic sclerosis: systematic review and meta-analysis.

Authors:  Manuel Rubio-Rivas; Cristina Royo; Carmen Pilar Simeón; Xavier Corbella; Vicent Fonollosa
Journal:  Semin Arthritis Rheum       Date:  2014-05-14       Impact factor: 5.532

3.  Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis.

Authors:  Carmen Pérez-Bocanegra; Roser Solans-Laqué; Carmen P Simeón-Aznar; Mercedes Campillo; Vicente Fonollosa-Pla; Miquel Vilardell-Tarrés
Journal:  Rheumatology (Oxford)       Date:  2010-03-11       Impact factor: 7.580

4.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

5.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

6.  Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study.

Authors:  Suparaporn Wangkaew; Narawudt Prasertwitayakij; Arintaya Phrommintikul; Saowanee Puntana; Juntima Euathrongchit
Journal:  Rheumatol Int       Date:  2017-10-12       Impact factor: 2.631

7.  A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.

Authors:  Virginia Steen; Robyn T Domsic; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2012-09

8.  Mortality and prognostic factors in Spanish patients with systemic sclerosis.

Authors:  C P Simeón; L Armadans; V Fonollosa; R Solans; A Selva; M Villar; J Lima; J Vaqué; M Vilardell
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

9.  Possible single-nucleotide polymorphism loci associated with systemic sclerosis susceptibility: a genetic association study in a Chinese Han population.

Authors:  Chang Shu; Wei Du; Xiaofei Mao; Yun Li; Qin Zhu; Wei Wang; Nan Wu; Xuming Mao; Hongzhong Jin; Qiuning Sun
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

10.  Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population.

Authors:  Jiucun Wang; Xinjian Guo; Lin Yi; Gang Guo; Wenzhen Tu; Wenyu Wu; Li Yang; Rong Xiao; Yuan Li; Haiyan Chu; Dongyi He; Li Jin; Maureen D Mayes; Hejian Zou; Xiaodong Zhou
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more
  7 in total

Review 1.  Detection and classification of systemic sclerosis-related interstitial lung disease: a review.

Authors:  Daniel J DeMizio; Elana J Bernstein
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

Review 2.  Systemic sclerosis in Asians: Are there racial differences?

Authors:  Sue-Ann Ng; Andrea Hsiu Ling Low
Journal:  J Scleroderma Relat Disord       Date:  2022-02-03

3.  Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: A systematic review and meta-analysis.

Authors:  Meihua Qiu; Xueyuan Nian; Lingling Pang; Pengfei Yu; Shenchun Zou
Journal:  Int J Rheum Dis       Date:  2021-08-21       Impact factor: 2.558

Review 4.  Systemic Scleroderma-Definition, Clinical Picture and Laboratory Diagnostics.

Authors:  Anna Kowalska-Kępczyńska
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

5.  Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival.

Authors:  DeAnna Baker Frost; Bethany Wolf; Christine Peoples; Jessica Fike; Katherine Silver; Maureen Laffoon; Thomas A Medsger; Carol Feghali-Bostwick
Journal:  Arthritis Res Ther       Date:  2019-04-02       Impact factor: 5.156

6.  Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis.

Authors:  Pierpaolo Palumbo; Piero Ruscitti; Paola Cipriani; Ernesto Di Cesare; Ester Cannizzaro; Onorina Berardicurti; Alessandro Conforti; Annamaria Di Cesare; Ilenia Di Cola; Roberto Giacomelli; Alessandra Splendiani; Antonio Barile; Carlo Masciocchi
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.379

7.  Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality.

Authors:  Sébastien De Almeida Chaves; Tiphaine Porel; Mickael Mounié; Laurent Alric; Léonardo Astudillo; Antoine Huart; Olivier Lairez; Martin Michaud; Grégoire Prévot; David Ribes; Laurent Sailler; Francis Gaches; Daniel Adoue; Gregory Pugnet
Journal:  Arthritis Res Ther       Date:  2021-12-07       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.